ALK-B:CPH
ALK-Abello A/S
DKKÂ 243.00
arrow_downward
-1.22%(-3.00) 1D
Nov 18, 5:00:00 PM GMT+1 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALK-B...
Open
DKKÂ 246.60
High
DKKÂ 248.00
Low
DKKÂ 239.40
Mkt. cap
49.83B
Avg. vol.
217.30K
Volume
348.47K
52-wk high
DKKÂ 271.40
52-wk low
DKKÂ 191.80
Shares outstanding
202.57M
No. of employees
3K
Open
DKKÂ 246.60
High
DKKÂ 248.00
Low
DKKÂ 239.40
Mkt. cap
49.83B
Avg. vol.
217.30K
Volume
348.47K
52-wk high
DKKÂ 271.40
52-wk low
DKKÂ 191.80
Shares outstanding
202.57M
No. of employees
3K
News stories
From web sources and news partners
MedWatch
·
13 hours ago
ALK scales back German investment to offset new drug rebate
Investing.com Canada
·
16 hours ago
ALK at Jefferies Global Healthcare Conference: growth broadens By Investing.com
www.tokenpost.com
·
1 day ago
ALK-Abelló A/S Q3 Revenue Rises 15% to DKK 1.76 Billion
Profile
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
About ALK-Abello A/S
CEOPeter Halling
Employees2.77K
Founded1923
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitealk.net